| Aug 14 |
Q2 2024 PAVmed Inc Earnings Call
|
| Aug 13 |
The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer
|
| Aug 13 |
PAVmed Provides Business Update and Second Quarter 2024 Financial Results
|
| Aug 12 |
Lucid Diagnostics Inc. (LUCD) Q2 2024 Earnings Call Transcript
|
| Aug 12 |
Lucid Diagnostics Non-GAAP EPS of -$0.20 misses by $0.02, revenue of $0.98M misses by $0.24M
|
| Aug 12 |
Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
|
| Aug 8 |
Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event
|
| Jul 30 |
PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
|
| Jul 29 |
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024
|
| Jul 29 |
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
|
